ID   KYSE-150R
AC   CVCL_C3LZ
DR   Wikidata; Q116049632
RX   PubMed=36090890;
CC   Population: Japanese.
CC   Characteristics: Radioresistant. Was irradiated at 1 Gy three times, at 2 Gy three times and 4 Gy three times (PubMed=36090890).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1348 ! KYSE-150
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
RX   PubMed=36090890; DOI=10.1155/2022/5632744; PMCID=PMC9452983;
RA   Gu Z.-L., Zhu W.-G., Wang W.-W., Xu Y.-Y., Jiang L., Huang J.-S.,
RA   Huang J.;
RT   "Anlotinib inhibits tumor angiogenesis and promotes the anticancer
RT   effect of radiotherapy on esophageal cancer through inhibiting
RT   EphA2.";
RL   J. Oncol. 2022:5632744.1-5632744.11(2022).
//